# Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert

> **NCT07391592** · — · ACTIVE_NOT_RECRUITING · sponsor: **MicroPort Orthopedics Inc.** · enrollment: 100 (actual)

## Conditions studied

- Osteoarthitis
- Arthritis Knee
- Joint Diseases
- Avascular Necrosis
- Rheumatoid Arthritis of Knee

## Interventions

- **DEVICE:** EVOLUTION® NitrX™

## Key facts

- **NCT ID:** NCT07391592
- **Lead sponsor:** MicroPort Orthopedics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-18
- **Primary completion:** 2032-12-31
- **Final completion:** 2032-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07391592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07391592, "Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07391592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*